Financial Toxicity After Acute Respiratory Distress Syndrome: A National Qualitative Cohort Study.

Critical Care Medicine
Katrina E HauschildtNational Heart, Lung, and Blood Institute (NHLBI) Prevention and Early Treatment of Acute Lung Injury (PETAL) Network

Abstract

The financial burdens and subsequent related distress of medical care, referred to as financial toxicity, may limit access to beneficial treatments. However, financial toxicity after acute care is less described-and may be an important but underexplored mechanism preventing full recovery after critical illnesses such as acute respiratory distress syndrome. We sought to identify the mechanisms by which financial toxicity manifested in patients with acute respiratory distress syndrome, protective factors against such toxicity, and the consequences of financial toxicity to survivors' lives following acute respiratory distress syndrome. We conducted semistructured interviews following patients' hospitalization and during recovery as an ancillary study to a multicenter randomized clinical trial in acute respiratory distress syndrome. Patients were 9-16 months post randomization at the time of interview. The Reevaluation Of Systemic Early Neuromuscular Blockade trial examined the use of early neuromuscular blockade in mechanically ventilated patients with moderate/severe acute respiratory distress syndrome. We recruited consecutive surviving patients who were English speaking, consented to follow-up, and were randomized between Decem...Continue Reading

References

Feb 21, 2003·The New England Journal of Medicine·Margaret S HerridgeUNKNOWN Canadian Critical Care Trials Group
Oct 6, 2005·Qualitative Health Research·Hsiu-Fang Hsieh, Sarah E Shannon
Jul 21, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Vicki A Freedman
Apr 8, 2011·The New England Journal of Medicine·Margaret S HerridgeUNKNOWN Canadian Critical Care Trials Group
Jun 3, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Didem S M BernardZhengyi Fang
Dec 18, 2013·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·A S AgårdI Egerod
Jan 23, 2016·Critical Care : the Official Journal of the Critical Care Forum·Ilse van BeusekomMarike van der Schaaf
Mar 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher S LathanDeborah Schrag
May 12, 2016·The New England Journal of Medicine·Jill I CameronUNKNOWN Canadian Critical Care Trials Group
Mar 6, 2018·Critical Care Medicine·Nita KhandelwalChristopher E Cox
Jul 19, 2018·Cancer Medicine·Theresa A HastertElectra D Paskett
Jan 9, 2019·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Allan GarlandClaudia Sanmartin
Apr 2, 2019·JAMA : the Journal of the American Medical Association·Tyler J VanderWeeleHoward K Koh
Apr 6, 2019·Annals of the American Thoracic Society·Candice C JohnsonRamona O Hopkins
May 3, 2019·Critical Care : the Official Journal of the Critical Care Forum·J M McPeakeT Quasim
May 22, 2019·The New England Journal of Medicine·UNKNOWN National Heart, Lung, and Blood Institute PETAL Clinical Trials NetworkDerek C Angus
Jun 12, 2019·Annals of the American Thoracic Society·Joanne McPeakeKimberley J Haines
Sep 25, 2019·Intensive Care Medicine·Nita KhandelwalJ Randall Curtis

❮ Previous
Next ❯

Citations

Jul 23, 2020·Critical Care Medicine·Helen See, Anthony D Slonim
Aug 11, 2020·Current Opinion in Critical Care·Hallie C PrescottW Joost Wiersinga
Feb 11, 2021·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Aluko A HopeCydni Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.